Search filters

List of works by David J. Riese

A constitutively active ErbB4 mutant inhibits drug-resistant colony formation by the DU-145 and PC-3 human prostate tumor cell lines.

scientific article published in March 2003

A high throughput, interactive imaging, bright-field wound healing assay.

scientific article

Activation of ErbB3, EGFR and Erk is essential for growth of human breast cancer cell lines with acquired resistance to fulvestrant

scientific article published on 14 April 2008

Activation of ErbB4 by the Bifunctional Epidermal Growth Factor Family Hormone Epiregulin Is Regulated by ErbB2

scientific article published on May 1, 1998

Altered EGFR localization and degradation in human breast cancer cells with an amphiregulin/EGFR autocrine loop.

scientific article published on 14 October 2008

Amphiregulin-EGFR signaling regulates PTHrP gene expression in breast cancer cells.

scientific article published on 20 September 2007

Anilinodialkoxyquinazolines: screening epidermal growth factor receptor tyrosine kinase inhibitors for potential tumor imaging probes.

scientific article published on November 2005

At the crossroads: EGFR and PTHrP signaling in cancer-mediated diseases of bone

scientific article published on June 10, 2012

Autocrine-derived epidermal growth factor receptor ligands contribute to recruitment of tumor-associated macrophage and growth of basal breast cancer cells in vivo.

scientific article published on January 2013

Cripto enhances the tyrosine phosphorylation of Shc and activates mitogen-activated protein kinase (MAPK) in mammary epithelial cells

scientific article

EGFR ligands exhibit functional differences in models of paracrine and autocrine signaling

scientific article

EGFR signaling in breast cancer: bad to the bone.

scientific article

Epiregulin: roles in normal physiology and cancer

scientific article published on 12 March 2014

ErbB2 Is Necessary for ErbB4 Ligands to Stimulate Oncogenic Activities in Models of Human Breast Cancer

scientific article published on August 2011

ErbB2 and ErbB3 do not quantitatively modulate ligand-induced ErbB4 tyrosine phosphorylation.

scientific article

Expression and purification of HER2 extracellular domain proteins in Schneider2 insect cells

scientific article published on 9 September 2015

Functional selectivity of EGF family peptide growth factors: implications for cancer

scientific article published on 16 December 2008

Ligand discrimination in signaling through an ErbB4 receptor homodimer.

scientific article published on June 2000

Ligand stimulation of ErbB4 and a constitutively-active ErbB4 mutant result in different biological responses in human pancreatic tumor cell lines.

scientific article

Ligand-based receptor tyrosine kinase partial agonists: New paradigm for cancer drug discovery?

scientific article published on February 2011

Lowe syndrome patient fibroblasts display Ocrl1-specific cell migration defects that cannot be rescued by the homologous Inpp5b phosphatase

scientific article

Modeling oncogene addiction using RNA interference.

scholarly article

Mutational activation of ErbB family receptor tyrosine kinases: insights into mechanisms of signal transduction and tumorigenesis

scientific article published on June 2007

Neuregulin isoforms exhibit distinct patterns of ErbB family receptor activation.

scientific article published on December 2002

Oncogenic activity of epidermal growth factor receptor kinase mutant alleles is enhanced by the T790M drug resistance mutation

scientific article

Phe45 of NRG2beta is critical for the affinity of NRG2beta for ErbB4 and for potent stimulation of ErbB4 signaling by NRG2beta*.

scientific article published on December 2005

Phosphorylation of ErbB4 on Tyr1056 is critical for inhibition of colony formation by prostate tumor cell lines.

scientific article published on 18 August 2006

Reconstitution of amphiregulin-epidermal growth factor receptor signaling in lung squamous cell carcinomas activates PTHrP gene expression and contributes to cancer-mediated diseases of the bone.

scientific article published on 13 October 2009

Specificity within the EGF family/ErbB receptor family signaling network

scientific article published on January 1, 1998

The Q43L mutant of neuregulin 2β is a pan-ErbB receptor antagonist.

scientific article published on April 2012

The antibody sc-33040-R fails to specifically recognize phosphorylation of ErbB4 on tyrosine1056

scientific article published on October 2007

The cellular response to neuregulins is governed by complex interactions of the erbB receptor family

scientific journal article

The epidermal growth factor receptor (EGFR)-S442F mutant displays increased affinity for neuregulin-2beta and agonist-independent coupling with downstream signalling events

scientific article published on May 2006